Sign In
Buy AUPH
$15.67
+0.280 (+1.82%)
At Close: Jun 03, 2026
Here's Why Everybody's Talking About Aurinia Pharmaceuticals Stock
06:27am, Wednesday, 27'th Jan 2021
Approval of a new lupus treatment has investors buzzing around this biotech stock.
Why Aurinia Pharmaceuticals Stock Is Flying Today
04:22pm, Monday, 25'th Jan 2021
The FDA approved the drugmaker's closely watched lupus nephritis therapy.
Why Aurinia Pharma, AstraZeneca And More Are Trading Higher Today
11:29am, Monday, 25'th Jan 2021
AstraZeneca (NASDAQ: AZN) shares are trading higher Monday after the company's CALQUENCE met its primary efficacy endpoint. The German Health Minister also said he expects the EU to approve the compan
Aurinia (AUPH) Gets FDA Nod for Kidney Disorder Drug Lupkynis
11:17am, Monday, 25'th Jan 2021
Aurinia (AUPH) gets approval from the FDA for Lupkynis as a treatment for active lupus nephritis, a disease that causes irreversible kidney damage.
FDA Approves Aurinia Pharmaceuticals' LUPKYNIS™ (voclosporin) for Adult Patients with Active Lupus Nephritis
08:24pm, Friday, 22'nd Jan 2021
VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia” or the “Company”) today announced that the U.S. Food and Drug Ad
Aurinia Pharmaceuticals to Present at Two Upcoming Virtual Healthcare Conferences
06:05am, Friday, 08'th Jan 2021
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced that members of the management team will participate in two upco
Aurinia (AUPH) Looks Good: Stock Adds 5.5% in Session
09:47am, Monday, 28'th Dec 2020
Aurinia (AUPH) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Aurinia Pharmaceuticals: An Update
10:11am, Monday, 21'st Dec 2020
AUPH stock has fallen on two recent developments. I analyze these and argue that the second, a new licensing agreement, is not negative, rather it's a positive for stockholders.
Aurinia Pharmaceuticals Offers Good Entry Opportunity Before Next PDUFA For Voclosporin
09:27am, Monday, 21'st Dec 2020
Aurinia Pharmaceuticals has one of the most important milestones in its history in a few weeks. Next January 22, 2021 is the PDUFA where the FDA will decide the approval of the candidate drug Voclospo
Unity Biotech, Aurinia Among Pharma Companies With R&D Flops in 2020
04:45pm, Friday, 18'th Dec 2020
Big names like Glaxo, Pfizer and Johnson & Johnson also abandoned promising programs
VICTORIA, British Columbia & ROCKVILLE, Md.--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX:AUP) (“Aurinia” or the “Company”) today announced it has entered into a collabora
Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity
05:59pm, Tuesday, 15'th Dec 2020
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (“Aurinia”) and Lonza Ltd. (SIX: LONN) ("Lonza") today announced they have expanded their exclus
Aurinia Pharmaceuticals to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference
06:05am, Wednesday, 02'nd Dec 2020
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH / TSX: AUP) (the “Company”) today announced its participation in the Piper Sandler 32nd Annual Virtual Healt
Top 10 Healthcare Stocks for the Future
06:44am, Sunday, 29'th Nov 2020
In this article we present the list of Top 10 Healthcare Stocks for the Future. Click to skip ahead and see the Top 5 Healthcare Stocks for the Future .
Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
05:00pm, Friday, 20'th Nov 2020
VICTORIA, British Columbia--(BUSINESS WIRE)--Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
